We are proud to announce that AIROS will again sponsor the annual “Run/Walk to Fight Lymphedema & Lymphatic Diseases,” presented by the Lymphatic Education & Research Network (LE&RN). Actor Kathy Bates is the national spokesperson for LE&RN.
May 2, 2019 Events Government Press Room
AIROS Medical Team Members Meet with Pennsylvania State Legislators in Harrisburg
Gerald Makoid, AIROS Medical president and CEO, and Darren Behuniak, vice president of operations and marketing, met with Pennsylvania state legislators in Harrisburg on Tuesday, April 30.
April 24, 2019 Events Press Room
AIROS Medical to Feature Compression Therapy Devices and Garments at 9th International Lymphedema Framework Conference
AIROS Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy, today announced it will present its line of compression therapy devices and garments at the 9th International Lymphedema Framework (ILF) Conference.
November 7, 2018 Events Industry Press Room
AIROS Medical Receives Excellent Feedback from Wound Care Experts at SAWC Fall 2018
AIROS Medical recently attended the Symposium for Advanced Wound Care’s (SAWC) Fall conference in Las Vegas, held from November 2-4. The event was the first public launch of AIROS’ new compression therapy device and garment line. Thousands of wound care professionals, including nurses, physicians, and administrative personnel, as well as podiatrists, physical therapists, and other […]
August 28, 2018 Events Industry Press Room
AIROS Medical Launches Sales of Compression Therapy Devices and Garments
AIROS Medical is excited to announce availability of its line of compression therapy devices, including the AIROS 6 Sequential Compression Device, the AIROS 8 Sequential Compression Device, and the devices’ accessory compression garment line.
June 22, 2018 Industry Press Room Regulatory
AIROS Medical Receives Two FDA 510(k) Clearances for Sequential Compression Devices
AIROS Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy, today announced it has received two 510(k) regulatory clearances to market medical devices from the U.S. Food and Drug Administration (FDA).